CASI Pharmaceuticals' IPO

CASI Pharmaceuticals raised a round of funding on June 13, 1996. Investors include Public.

CASI Pharmaceuticals, formerly EntreMed, is a biopharmaceutical company focused on the acquisition, development, and commercialization of innovative therapeutics addressing CANCER and other unmet medi…

Articles about CASI Pharmaceuticals' IPO: